CODX · Co-Diagnostics, Inc. · Investor Relations
$0.26
-0.01 (-4.12%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that substantial doubt exists about the Company’s ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued. These uncertainties create substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$2.72M
Shares
10.51M
Volume · Nov 13
591.94K
Avg daily vol (3M)
1.97M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-10 | Q3 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-09-16 | Co-Diagnostics - Special Presentation | Presentation |
| 2026-08-13 | Co-Diagnostics, Inc. Second Quarter 2026 Earnings Webcast | Earnings call |
| 2026-05-14 | Co-Diagnostics, Inc. First Quarter 2026 Earnings Webcast | Earnings call |
| 2026-03-31 | Co-Diagnostics, Inc. Full Year 2025 Earnings Webcast | Earnings call |
Source: https://ir.co-dx.com/
Key facts
CIK
1692415
CUSIP
189763204
13F (30d)
30 filings
20 filers
Visit website
Investor relations